Suppr超能文献

α-生育酚负载纳米乳系统的理化性质及药理学特征。

Physicochemical and pharmacological characterization of alpha-tocopherol-loaded nano-emulsion system.

机构信息

Department of Pharmacokinetics and Pharmacodynamics and Global Center of Excellence (COE) Program, School of Pharmaceutical Sciences, University of Shizuoka, 52-1, Yada, Suruga-ku, Shizuoka, 422-8526, Japan.

出版信息

Int J Pharm. 2010 Aug 30;396(1-2):188-93. doi: 10.1016/j.ijpharm.2010.06.017. Epub 2010 Jun 15.

Abstract

The main purpose of the present study is to develop a novel nano-emulsion (NE) formulation of alpha-tocopherol (alpha-TC) with enhanced oral bioavailability and pharmacological effects. Three NE formulations of alpha-TC at different loading amounts (10%, 30% and 50%) were prepared by a mechanochemical method. Physicochemical properties of NE formulations were characterized with a focus on the morphology by transmission electron microscopy (TEM), droplet size distribution and zeta-potential by dynamic light scattering (DLS), and long-term stability. According to the TEM images and DLS data, mean diameters of NE droplets ranged from 80 to 400nm, in proportion to the amount of loaded alpha-TC. Although all NE formulations of alpha-TC were found to be negatively charged with the zeta-potential of ca -40mV, NE formulations at alpha-TC content of 30% or higher exhibited severe aggregation of droplets in NE formulations during long-term storage. After oral administration of 10% alpha-TC-loaded NE formulation (30mg alpha-TC/kg) in rats, higher alpha-TC exposure was observed with a 2.6-fold increase of bioavailability as compared to the control mixture of oil and alpha-TC. In streptozotocin-induced diabetic rats, oral administration of the alpha-TC-loaded NE formulation (30mg alpha-TC/kg) exhibited a significant reduction of lipoperoxidant in several organs, especially the liver; however, the control mixture was less effective. With these findings, the NE approach might be efficacious to improve the oral bioavailability and anti-oxidative activities of alpha-TC.

摘要

本研究的主要目的是开发一种新型的α-生育酚(α-TC)纳米乳(NE)制剂,以提高其口服生物利用度和药理作用。采用机械化学法制备了三种不同载药量(10%、30%和 50%)的α-TC NE 制剂。重点考察了制剂的形态学特性,采用透射电子显微镜(TEM)观察形态,采用动态光散射(DLS)法测定粒径分布和zeta 电位,考察了制剂的长期稳定性。根据 TEM 图像和 DLS 数据,NE 液滴的平均直径范围为 80-400nm,与载药量呈正相关。尽管所有载有 α-TC 的 NE 制剂均带负电荷,zeta 电位约为-40mV,但当载药量为 30%或更高时,NE 制剂在长期储存过程中会出现液滴严重聚集。在大鼠口服 10%载有 α-TC 的 NE 制剂(30mg α-TC/kg)后,与对照油和 α-TC 混合物相比,α-TC 的暴露量增加了 2.6 倍,生物利用度提高。在链脲佐菌素诱导的糖尿病大鼠中,口服载有 α-TC 的 NE 制剂(30mg α-TC/kg)可显著降低几个器官,尤其是肝脏中的脂质过氧化产物;然而,对照混合物的效果较差。有这些发现,NE 方法可能有效提高 α-TC 的口服生物利用度和抗氧化活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验